WARSAW, Ind., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Symmetry Medical Inc. (NYSE:SMA), a leading global source of innovative medical device solutions, including orthopedic implants, surgical instruments, and sterilization cases and trays, announced today that it will release fourth quarter and full year 2012 financial results for the period ending December 29, 2012 before the market opens on Thursday, February 21, 2013. Symmetry Medical will host an accompanying conference call at 8:00 a.m. ET on Thursday, February 21, 2013.

A live webcast of the conference call will be available online from the investor relations page of the Company's corporate website at www.symmetrymedical.com. The dial-in numbers are (888) 771-4371 for domestic callers and (847) 585-4405 for international. The reservation number for both is 34152034 (please reference "Zack Kubow" as host and "Symmetry Medical" as the Company). After the live webcast, the call will remain available on Symmetry Medical's website through May 21, 2013. In addition, a telephonic replay of the call will be available until February 27, 2013. The replay numbers are (888) 843-7419 for domestic callers and (630) 652-3042 for international callers. Please use reservation code 34152034.

About Symmetry Medical Inc.

Symmetry Medical Inc. is a leading global source of innovative medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company's thousands of Teammates provide design, development and worldwide production capabilities for these products to customers in the orthopedic industry, other medical device markets, and specialized non-healthcare markets. Symmetry's trusted reputation and brands, broad Intellectual Property portfolio and commitment to innovation enable it to collaborate with hundreds of global medical device manufacturers as well as thousands of hospitals to provide solutions for today's needs and tomorrow's growth.
CONTACT: Symmetry Medical Inc.         Fred L. Hite         Senior Vice President         Chief Financial Officer         (574) 371-2218                  Investors:         The Ruth Group         Zack Kubow         (646) 536-7020         zkubow@theruthgroup.com